Tag Archives: Margaret A. Hamburg

Is the US Facing a Pharma Manufacturing Gap?

By Patricia Van Arnum, Pharmaceutical Technology. Last week, FDA Commissioner Margaret A. Hamburg testified before the House Committee on Energy and Commerce, Subcommittee on Health to outline the agency’s case for supporting the fifth authorization of the Prescription Drug User Fee Act (PDUFA), also known as PDUFA V. In addition to offering her support for […]
Posted in Guest Blog, Manufacturing, Regulatory | Also tagged , , | Leave a comment
  • Categories

  • Meta